Is Virtus LifeSci Biotech Clinical Trials ETF halal to invest in?

As of September 2026, Virtus LifeSci Biotech Clinical Trials ETF BBC is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Virtus LifeSci Biotech Clinical Trials ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Virtus LifeSci Biotech Clinical Trials ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Virtus LifeSci Biotech Clinical Trials ETF updated?

The Shariah compliance status of Virtus LifeSci Biotech Clinical Trials ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Virtus LifeSci Biotech Clinical Trials ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Virtus LifeSci Biotech Clinical Trials ETF?

You can check the latest Shariah compliance status of Virtus LifeSci Biotech Clinical Trials ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Virtus LifeSci Biotech Clinical Trials ETF BBC

BBC Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Virtus LifeSci Biotech Clinical Trials ETF is classified as not halal.

NOT HALAL

Is Virtus LifeSci Biotech Clinical Trials ETF Halal?

Shariah Compliance Analysis of BBC ETF

US Equity Health Care

No. As of September 2026, Virtus LifeSci Biotech Clinical Trials ETF (BBC) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Virtus LifeSci Biotech Clinical Trials ETF does not pass Musaffa's business and financial screening criteria.

BBC was created on 2014-12-16 by Virtus. The fund's investment portfolio concentrates primarily on health care equity. BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Chart

Key Statistics of Virtus LifeSci Biotech Clinical Trials ETF (BBC)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
97.29%
Other
2.71%

FAQ's for Virtus LifeSci Biotech Clinical Trials ETF (BBC)

As of September 2026, Virtus LifeSci Biotech Clinical Trials ETF BBC is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Virtus LifeSci Biotech Clinical Trials ETF using these criteria to determine its compliance status.
The Shariah compliance status of Virtus LifeSci Biotech Clinical Trials ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Virtus LifeSci Biotech Clinical Trials ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.